Related Experiment Video
Updated: Jul 12, 2025

Assisted Selection of Biomarkers by Linear Discriminant Analysis Effect Size LEfSe in Microbiome Data
Published on: May 16, 2022
Machine learning-based feature selection to search stable microbial biomarkers: application to inflammatory bowel
Youngro Lee1,2, Marco Cappellato3, Barbara Di Camillo3
1Department of Electrical and Computer Engineering, Seoul National University, Seoul, 08826, Korea.
Improving microbiome biomarker discovery for inflammatory bowel disease (IBD) is crucial. This study enhances feature selection stability using data transformation and Bray-Curtis similarity, identifying 14 species-level IBD biomarkers.
Area of Science:
- Microbiome research
- Bioinformatics
- Machine learning applications in health
Background:
- Machine learning, particularly recursive feature elimination (RFE), is used for microbiome biomarker discovery.
- Existing RFE methods face challenges with feature selection stability.
- This study addresses the need for more stable and reliable feature selection in microbiome analysis.
Purpose of the Study:
- To enhance the stability of feature selection in microbiome biomarker discovery.
- To identify robust biomarkers for inflammatory bowel disease (IBD) using improved machine learning techniques.
- To evaluate different data transformation methods for optimizing stability and performance.
Main Methods:
- Utilized gut microbiome abundance matrices from 1,569 samples (IBD patients and healthy controls).
- Applied data transformation, including Bray-Curtis similarity mapping, prior to recursive feature elimination (RFE).
- Evaluated feature selection stability using multiple metrics and compared 8 machine learning algorithms (Multilayer Perceptron, Random Forest).
Main Results:
- Data transformation, specifically Bray-Curtis similarity mapping before RFE, significantly improved feature selection stability.
- The developed pipeline maintained high classification performance for IBD detection.
- Identified 14 species-level biomarkers for IBD, with roles analyzed using Shapley additive explanations.
- Random Forest outperformed other algorithms for generalizability with a limited biomarker set.
Conclusions:
- The study presents a method to improve biomarker discovery stability in metataxonomics without compromising classification performance.
- The findings offer valuable insights for future comparative microbiome studies.
- The identified IBD biomarkers and optimized pipeline contribute to advancing microbiome-based diagnostics.
More Related Videos
07:35Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018
10:37Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
MALDI-TOF Mass Spectrometry
Matrix-assisted laser desorption ionization (MALDI) is a commonly...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...